Reaction Details Report a problem with these data
Target
Nucleoprotein
Ligand
BDBM601555
Substrate
n/a
Meas. Tech.
Plaque Reduction Assay
EC50
19.0±n/a nM
Citation
 Cockerill, GS; Good, J; Cochrane, EJ Pharmaceutical compounds US Patent  US11634425 Publication Date 4/25/2023 
Target
Name:
Nucleoprotein
Synonyms:
N | NCAP_HRSVA | Nucleocapsid protein | Protein N
Type:
PROTEIN
Mol. Mass.:
43455.45
Organism:
Human respiratory syncytial virus A (strain A2)
Description:
ChEMBL_117398
Residue:
391
Sequence:
MALSKVKLNDTLNKDQLLSSSKYTIQRSTGDSIDTPNYDVQKHINKLCGMLLITEDANHKFTGLIGMLYAMSRLGREDTIKILRDAGYHVKANGVDVTTHRQDINGKEMKFEVLTLASLTTEIQINIEIESRKSYKKMLKEMGEVAPEYRHDSPDCGMIILCIAALVITKLAAGDRSGLTAVIRRANNVLKNEMKRYKGLLPKDIANSFYEVFEKHPHFIDVFVHFGIAQSSTRGGSRVEGIFAGLFMNAYGAGQVMLRWGVLAKSVKNIMLGHASVQAEMEQVVEVYEYAQKLGGEAGFYHILNNPKASLLSLTQFPHFSSVVLGNAAGLGIMGEYRGTPRNQDLYDAAKAYAEQLKENGVINYSVLDLTAEELEAIKHQLNPKDNDVEL
  
Inhibitor
Name:
BDBM601555
Synonyms:
2-(2,4- Difluorophenyl)-N- [(3S)-9-fluoro-2-oxo- 5-phenyl-1,3- dihydro-1,4- benzodiazepin-3- yl]imidazo[1,2- b]pyridazine-3- carboxamide | US11634425, Example 89
Type:
Small organic molecule
Emp. Form.:
C28H17F3N6O2
Mol. Mass.:
526.4688
SMILES:
Fc1ccc(-c2nc3cccnn3c2C(=O)N[C@H]2N=C(c3ccccc3)c3cccc(F)c3NC2=O)c(F)c1 |t:20|
Structure:
Search PDB for entries with ligand similarity: